| ASCFX | NAESX | ASCFX / NAESX | |
| Total Expense Ratio | 0.77 | 0.17 | 453% |
| Annual Report Gross Expense Ratio | 0.90 | 0.17 | 529% |
| Fund Existence | 8 years | 66 years | - |
| Gain YTD | 21.176 | 18.339 | 115% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 134M | 183B | 0% |
| Annual Yield % from dividends | 0.24 | 1.10 | 22% |
| Returns for 1 year | 21.67 | 24.75 | 88% |
| Returns for 3 years | 44.77 | 58.17 | 77% |
| Returns for 5 years | 12.04 | 42.07 | 29% |
| Returns for 10 years | N/A | 156.41 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIPIX | 102.24 | 2.17 | +2.17% |
| ProFunds Biotechnology UltraSector Inv | |||
| FMACX | 46.32 | 0.26 | +0.56% |
| American Fds AMCAP F-3 | |||
| RSEFX | 18.14 | 0.07 | +0.39% |
| Royce Small-Cap Special Equity Svc | |||
| CFXRX | 16.52 | 0.05 | +0.30% |
| Columbia Flexible Capital Income Inst2 | |||
| FRIQX | 12.40 | N/A | N/A |
| Fidelity Advisor Real Estate Income M | |||